Table 1.
Patient sociodemographic characteristics and their associations with the presence of an oncologist during a scan results discussion in the propensity‐weighted sample
| Patient characteristics | Unweighted | P | Weighted | P | ||||
|---|---|---|---|---|---|---|---|---|
| Overall | Oncologist Absent | Oncologist Present | Overall | Oncologist Absent | Oncologist Present | |||
| N | n (%) | n (%) | N | n (%) | n (%) | |||
| 209 | 64 (30.6) | 145 (69.4) | 207.1 | 62.6 (30.2) | 144.5 (69.8) | |||
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
| Age in years | 60.1 (9.7) | 58.8 (9.8) | 60.7 (9.6) | 0.193 | 60.5 (8.9) | 60.7 (8.3) | 60.4 (9.1) | 0.873 |
| Education in years | 14.5 (3.2) | 13.6 (3.8) | 14.8 (2.8) | 0.023 | 14.4 (3.1) | 14.4 (3.7) | 14.5 (2.8) | 0.816 |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||
| Gender | ||||||||
| Male | 68 (32.5) | 17 (26.6) | 51 (35.2) | 0.221 | 62.0 (30.0) | 15.8 (25.3) | 46.2 (32.0) | 0.339 |
| Female | 141 (67.5) | 47 (73.4) | 94 (64.8) | 145.0 (70.0) | 46.7 (74.7) | 98.3 (68.0) | ||
| Race | ||||||||
| White | 177 (84.7) | 53 (82.8) | 124 (85.5) | 0.617 | 178.4 (86.1) | 55.0 (87.9) | 123.4 (85.4) | 0.634 |
| Non‐White | 32 (15.3) | 11 (17.2) | 21 (14.5) | 28.7 (13.9) | 7.6 (12.1) | 21.1 (14.6) | ||
| Ethnicity | ||||||||
| Latino | 19 (9.1) | 5 (7.8) | 14 (9.7) | 0.669 | 23.5 (11.3) | 9.6 (15.3) | 13.9 (9.6) | 0.239 |
| Non‐Latino | 190 (90.9) | 59 (92.2) | 131 (90.3) | 183.6 (88.7) | 53.0 (84.7) | 130.6 (90.4) | ||
| Insurance status | ||||||||
| Insured | 159 (76.1) | 40 (62.5) | 119 (82.1) | 0.002 | 156.8 (75.7) | 47.4 (75.8) | 109.4 (75.7) | 0.993 |
| Not Insured | 50 (23.9) | 24 (37.5) | 26 (17.9) | 50.3 (24.3) | 15.2 (24.2) | 35.1 (24.3) | ||
| Marital status | ||||||||
| Married | 122 (58.4) | 33 (51.6) | 89 (61.4) | 0.185 | 127.4 (61.5) | 39.6 (63.3) | 87.8 (60.8) | 0.733 |
| Not Married | 87 (41.6) | 31 (48.4) | 56 (38.6) | 79.6 (38.5) | 23.0 (36.7) | 56.7 (39.2) | ||
| Primary cancer | ||||||||
| Lung | 65 (31.1) | 25 (39.1) | 40 (27.6) | 0.001 | 72.8 (35.1) | 24.9 (39.8) | 47.9 (33.1) | 0.416 |
| Gastrointestinal | 63 (30.1) | 8 (12.5) | 55 (37.9) | 56.9 (27.5) | 13.5 (21.5) | 43.4 (30.1) | ||
| Other | 81 (38.8) | 31 (48.4) | 50 (34.5) | 77.4 (37.4) | 24.2 (38.6) | 53.2 (36.8) | ||
| Clinic site | ||||||||
| New England | 127 (60.8) | 33 (51.6) | 94 (64.8) | <0.001 | 128.9 (62.2) | 40.4 (64.6) | 88.5 (61.2) | 0.802 |
| Mid‐Atlantic/South | 28 (13.4) | 3 (4.7) | 25 (17.2) | 26.0 (12.6) | 6.4 (10.3) | 19.5 (13.5) | ||
| Southwest/West | 54 (25.8) | 28 (43.8) | 26 (17.9) | 52.2 (25.2) | 15.7 (25.1) | 36.5 (25.3) | ||
SD, standard deviation.
New England: Dana‐Farber/Harvard Cancer Center, Yale Cancer Center.
Mid‐Atlantic/South: Memorial Sloan Kettering Cancer Center, Meyer Cancer Center at Weill Cornell Medicine, Virginia Commonwealth University Massey Cancer Center.
Southwest/West: Parkland Hospital, University of New Mexico Cancer Center, Pomona Valley Hospital Medical Center.